NASH-FX trial shows excellent reproducibility of cT1 as a non-invasive biomarker of liver health

LiverMultiScan™ receives regulatory clearance in Singapore

Liver Physicians Pioneering National Digital Health Strategy with GE Healthcare

Data Released at The Liver Meeting ® 2018 Shows MRCP+ is a Promising Non-Invasive Technology for Quantitative Evaluation of Hepatobiliary Diseases

Predicting Clinical Outcomes with Multiparametric MRI Featuring Liver cT1 Equal to Biopsy

Press Release | Perspectum Diagnostics Showcases Quantitative MR-Based Biomarkers for Liver and Hepatobiliary Health at RSNA

Perspectum Diagnostics Named in Top 100 Fastest Growing Companies